Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa.

Takyi, Abena; Carrara, Verena I; Dahal, Prabin; Przybylska, Marianna; Harriss, Eli; Insaidoo, Genevieve; Barnes, Karen I; Guerin, Philippe J; Stepniewska, Kasia

Takyi, Abena; Carrara, Verena I; Dahal, Prabin; Przybylska, Marianna; Harriss, Eli; Insaidoo, Genevieve; Barnes, Karen I; Guerin, Philippe J; Stepniewska, Kasia.

Afiliação

Takyi A; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Carrara VI; Infectious Diseases Data Observatory (IDDO), Oxford, United Kingdom.
Dahal P; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.
Przybylska M; Department of Child Health, Korle Bu Teaching Hospital, Accra, Ghana.
Harriss E; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Insaidoo G; Infectious Diseases Data Observatory (IDDO), Oxford, United Kingdom.
Barnes KI; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.
Guerin PJ; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Stepniewska K; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

PLOS Glob Public Health ; 3(12): e0002059, 2023.

Article em En | MEDLINE | ID: mdl-38039291

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article